Skip to content
中文产业新闻评分28Chinese source

减重持续加码、增肌仍待突破:罗氏终止 Emugrobart 肥胖治疗开发

减重持续加码 增肌仍待突破

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.